AbClon
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymph B-cell Non Hodgkin Lymphoma | Phase 1 / Phase 2 | 2022-03-15 |